Comparable to MYD88 mutation, according to RNA sequencing data, significant upregulation of macrophage activation pathways and infiltration of M2 macrophages were presented in CD5+ non-DE DLBCL, indicating the crucial role of immunosuppressive cells in this subgroup. Here, MYD88 is linked to diffuse large B-cell lymphoma.